SHIRE PLC: Transaction in Own Shares

Transaction in Own Shares 
February 11, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"),
announces that in accordance with the authority granted by shareholders at the
Company's Annual General Meeting on April 24, 2012 it purchased 21,050 of its
ordinary shares of 5 pence each ("Ordinary Shares") on February 8, 2013 through
both direct purchases of Ordinary Shares and through the purchase of Ordinary
Shares underlying ADRs. The highest and lowest price paid for the directly
acquired Ordinary Shares was 2123.00 pence per share and 2104.00 pence per
share respectively and for those Ordinary Shares acquired through the purchase
of ADRs was 3345.00 cents per share and 3333.33 cents per share respectively. 
The purchased shares will be held as treasury shares. Following the above
purchase, the Company holds 4,759,774 Ordinary Shares as treasury shares and
has 557,799,700 Ordinary Shares in issue (excluding treasury shares). 
The purchases were made by an independent third party which makes its trading
decisions independently of, and uninfluenced by the Company. The independence
of the third party enables the Company to continue to purchase Ordinary Shares
(including Ordinary Shares underlying ADRs) during close periods and other
prohibited periods, should they arise. The third party has been appointed by
the Company to make purchases to December 31, 2013. 
For further information please contact: 
Investor Relations                                                              
                                                                           
Eric Rojas                              erojas@shire.com     +1 781 482 0999    
                                                                           
Sarah Elton-Farr                        seltonfarr@shire.com +44 1256 894157    
Notes to editors 
Shire enables people with life-altering conditions to lead better lives. 
Through our deep understanding of patients' needs, we develop and provide
healthcare in the areas of: 
* Behavioral Health and Gastro Intestinal conditions 


      * Rare Diseases
      * Regenerative Medicine
    as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for
patients, physicians, policymakers, payors and our shareholders.


                                                                          
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX 
Press Release                                      
                                              
www.shire.com                                      
END 
-0- Feb/11/2013 07:29 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.